ALZERTA DOS POR SEMANA 9,5 MG/24 H PARCHES TRANSDERMICOS

Esteve Pharmaceuticals S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 904723a271dd238f
Drug Cima Aemps Name: ALZERTA DOS POR SEMANA 9,5 MG/24 H PARCHES TRANSDERMICOS
Register Number: 86149
Holder Company Name: Esteve Pharmaceuticals S.A.
Marketing Company Name: Esteve Pharmaceuticals S.A.
Holder Company Detail Path: /organization/esteve-pharmaceuticals-s-a
Marketing Company Detail Path: /organization/esteve-pharmaceuticals-s-a
Authorization Date: 2021-08-09
Dosage Form: PARCHE TRANSDÉRMICO
Dose: 9,5 mg/24 h
Route Of Administration: VÍA TRANSDÉRMICA
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Esteve Pharmaceuticals S.A.
Company Detail Path: /organization/esteve-pharmaceuticals-s-a

RIVASTIGMINA

51,84 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 9, 2021

Approval ID

904723a271dd238f

Type

Standard